Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Ostroski who wrote (2919)	12/1/1997 11:32:00 AM
From: Brian Pastor	Respond to of 23519

Stock is looking fine. All that happened this morning is that individual investors bought in while it is readily apparent some institutional and large traders are unwinding their positions here because of year-end issues. This approval will mean a real upward kick for earnings next year - remember, VVUS has been stockpiling MUSE in Europe so it is ready to sell there immediatly. It's only hurdle there is to quickyl educate the doctors over there on the drug's incredible effectiveness. This means great things for VVUS earnings which you can now expect a number of upward revisions.